Sumitomo Seika Chemicals Company, Limited. (TYO:4008)
Japan · Delayed Price · Currency is JPY 5,480.00
-20.00 (-0.36%)
Feb 6, 2026, 3:30 PM JST
TYO:4008 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 146,301 | 147,571 | 142,986 | 143,041 | 115,583 | 103,254 | |
Revenue Growth (YoY) | -0.68% | 3.21% | -0.04% | 23.76% | 11.94% | 3.56% |
Cost of Revenue | 114,308 | 116,890 | 114,979 | 112,905 | 89,434 | 78,078 |
Gross Profit | 31,993 | 30,681 | 28,007 | 30,136 | 26,149 | 25,176 |
Selling, General & Admin | 17,599 | 17,344 | 15,766 | 17,010 | 15,486 | 12,193 |
Research & Development | 2,704 | 2,624 | 2,711 | 2,670 | 2,590 | 2,881 |
Operating Expenses | 20,303 | 19,968 | 18,477 | 19,680 | 18,076 | 15,074 |
Operating Income | 11,690 | 10,713 | 9,530 | 10,456 | 8,073 | 10,102 |
Interest Expense | -277 | -286 | -397 | -286 | -245 | -255 |
Interest & Investment Income | 553 | 649 | 844 | 558 | 168 | 133 |
Currency Exchange Gain (Loss) | -31 | 88 | 280 | 44 | 676 | 87 |
Other Non Operating Income (Expenses) | 21 | -59 | -11 | 156 | 242 | 307 |
EBT Excluding Unusual Items | 11,956 | 11,105 | 10,246 | 10,928 | 8,914 | 10,374 |
Gain (Loss) on Sale of Investments | 943 | 122 | 37 | 429 | 26 | 47 |
Gain (Loss) on Sale of Assets | - | - | 2 | - | - | 34 |
Asset Writedown | -1,686 | -1,502 | -834 | -109 | -488 | -791 |
Other Unusual Items | -2,587 | -1,403 | -730 | - | - | - |
Pretax Income | 8,626 | 8,322 | 8,721 | 11,248 | 8,452 | 9,664 |
Income Tax Expense | 2,719 | 2,361 | 2,555 | 2,624 | 2,499 | 2,331 |
Earnings From Continuing Operations | 5,907 | 5,961 | 6,166 | 8,624 | 5,953 | 7,333 |
Minority Interest in Earnings | - | - | - | -32 | -58 | -214 |
Net Income | 5,907 | 5,961 | 6,166 | 8,592 | 5,895 | 7,119 |
Net Income to Common | 5,907 | 5,961 | 6,166 | 8,592 | 5,895 | 7,119 |
Net Income Growth | -10.90% | -3.33% | -28.24% | 45.75% | -17.19% | 66.14% |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 14 | 14 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 14 | 14 |
Shares Change (YoY) | -1.54% | -1.53% | -0.43% | -1.80% | -0.38% | - |
EPS (Basic) | 449.83 | 450.60 | 458.98 | 636.82 | 429.04 | 516.17 |
EPS (Diluted) | 449.83 | 450.60 | 458.98 | 636.82 | 429.04 | 516.17 |
EPS Growth | -9.51% | -1.83% | -27.93% | 48.43% | -16.88% | 66.14% |
Free Cash Flow | -2,036 | -5,977 | 3,797 | 1,800 | 5,388 | 13,177 |
Free Cash Flow Per Share | -155.05 | -451.81 | 282.64 | 133.41 | 392.14 | 955.41 |
Dividend Per Share | 200.000 | 200.000 | 200.000 | 200.000 | 120.000 | 100.000 |
Dividend Growth | - | - | - | 66.67% | 20.00% | - |
Gross Margin | 21.87% | 20.79% | 19.59% | 21.07% | 22.62% | 24.38% |
Operating Margin | 7.99% | 7.26% | 6.67% | 7.31% | 6.98% | 9.78% |
Profit Margin | 4.04% | 4.04% | 4.31% | 6.01% | 5.10% | 6.89% |
Free Cash Flow Margin | -1.39% | -4.05% | 2.66% | 1.26% | 4.66% | 12.76% |
EBITDA | 17,070 | 16,450 | 15,277 | 15,553 | 12,969 | 15,382 |
EBITDA Margin | 11.67% | 11.15% | 10.68% | 10.87% | 11.22% | 14.90% |
D&A For EBITDA | 5,380 | 5,737 | 5,747 | 5,097 | 4,896 | 5,280 |
EBIT | 11,690 | 10,713 | 9,530 | 10,456 | 8,073 | 10,102 |
EBIT Margin | 7.99% | 7.26% | 6.67% | 7.31% | 6.98% | 9.78% |
Effective Tax Rate | 31.52% | 28.37% | 29.30% | 23.33% | 29.57% | 24.12% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.